Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-05-03 Purchase |
2024-10-21 8:22 pm |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
922 | $11.33 | $10,447 | 922 (Direct) |
View |
2023-11-08 Sale |
2023-11-13 2:44 pm |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
8,111 | $19 | $154,109 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-04 Option Award |
2024-06-06 4:12 pm |
N/A 2034-06-03 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
42,018 | $0 | 42,018 (Direct) |
View |
2024-05-21 Option Award |
2024-05-23 7:12 pm |
N/A 2034-05-20 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
22,500 | $0 | 22,500 (Direct) |
View |
2023-11-08 Equity Swap |
2023-11-13 2:44 pm |
N/A N/A |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
22,304 | $19 | 0 (Direct) |
View |
2023-06-30 Option Award |
2023-07-05 5:42 pm |
N/A 2033-06-29 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
22,137 | $0 | 22,137 (Direct) |
View |
2023-05-24 Option Award |
2023-05-25 8:38 pm |
N/A 2033-05-24 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
20,658 | $0 | 42,962 (Direct) |
View |
2023-05-23 Option Award |
2023-05-25 7:37 pm |
N/A 2033-05-22 |
4D Molecular Therapeutics Inc. | FMDT | Miller-Rich Nancy Director |
22,500 | $0 | 22,500 (Direct) |
View |
2022-06-07 Option Award |
2022-06-09 5:07 pm |
N/A 2032-06-06 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
56,131 | $0 | 56,131 (Direct) |
View |
2022-05-25 Option Award |
2022-05-27 4:17 pm |
N/A 2032-05-25 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
20,527 | $0 | 35,094 (Direct) |
View |
2022-05-23 Option Award |
2022-05-25 7:02 pm |
N/A 2032-05-22 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
22,500 | $0 | 22,500 (Direct) |
View |
2021-06-08 Option Award |
2021-06-10 5:46 pm |
N/A 2031-06-07 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
14,117 | $0 | 14,117 (Direct) |
View |
2021-05-27 Option Award |
2021-06-01 7:02 pm |
N/A 2031-05-27 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
19,118 | $0 | 26,656 (Direct) |
View |
2021-05-17 Option Award |
2021-05-19 8:32 pm |
N/A 2031-05-16 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
22,500 | $0 | 22,500 (Direct) |
View |
2021-05-12 Option Award |
2021-05-13 4:16 pm |
N/A 2031-05-12 |
Kadmon Holdings Inc. | KDMN | Miller-Rich Nancy Director |
96,975 | $0 | 96,975 (Direct) |
View |
Ownership |
2020-12-10 8:14 pm |
N/A 2030-11-11 |
4D Molecular Therapeutics Inc. | FDMT | Miller-Rich Nancy Director |
0 | $0 | 45,000 (Direct) |
View |
2020-08-13 Option Award |
2020-08-13 5:19 pm |
N/A 2030-08-13 |
Kadmon Holdings Inc. | KDMN | Miller-Rich Nancy Director |
36,364 | $4.17 | 36,364 (Direct) |
View |
2020-06-09 Option Award |
2020-06-11 5:48 pm |
N/A 2030-06-08 |
Aldeyra Therapeutics Inc. | ALDX | Miller-Rich Nancy Director |
26,503 | $0 | 26,503 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 7:03 pm |
N/A 2030-05-28 |
INTERCEPT PHARMACEUTICALS INC. | ICPT | Miller-Rich Nancy Director |
4,561 | $0 | 10,504 (Direct) |
View |